bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.01.08.631816

Multivariable Mendelian Randomization adjusting for heritable confounding analyzes the causal effects of C-reactive protein on multiple diseases

Abstract

BackgroundC-reactive protein (CRP) is a marker of inflammation associated with autoimmune, cardiovascular, and neuropsychiatric disorders. However, it remains unclear whether CRP causally affects these traits or if observed associations result from reverse causation or confounding. Mendelian randomization (MR) uses genetic variants as instrumental variables to estimate causal effects and avoid the biases present in observational studies. Prior MR studies have suggested causal effects of CRP on several traits, including schizophrenia, bipolar disorder, and colorectal cancer. However, MR may produce biased results if factors that confound the exposure and outcome are heritable, resulting in horizontal pleiotropy. This is a major concern for studies of CRP, because CRP levels may increase in response to inflammation caused by a wide range of heritable conditions. MethodsMultivariable Mendelian randomization (MVMR) can be used to eliminate bias from heritable confounding when GWAS summary data are available for confounders. In this study, we use MVMR to estimate the causal effects of CRP on 12 outcomes with prior evidence of a causal or associational link to CRP. We use a novel computational pipeline to identify a broad set of potential heritable confounders between CRP and each outcome trait from studies in the MRC-IEU OpenGWAS database. We compare MVMR results with computationally selected confounders to univariable MR results and MVMR using a narrower, literature derived set of confounders. ResultsWe find that univariable MR suggests evidence of a potential risk-increasing effect of CRP on coronary artery disease, knee osteoarthritis, and rheumatoid arthritis, and a protective effect on schizophrenia. However, after adjusting for computationally selected heritable confounders, only the causal effects on rheumatoid arthritis (OR 1.18, 95% CI [1.07,1.31], p=0.0010 by GRAPPLE) and schizophrenia (OR 0.87, 95% CI [0.79,0.96], p=0.0038 by GRAPPLE) remain significant. Additionally, after adjusting for confounders we find evidence of a potential protective effect of CRP on bipolar disorder at the nominal significance level, which is not observed in the univariable analysis. ConclusionThese results suggest that univariable MR analyses of CRP may be biased by high levels of heritable confounding, though CRP may indeed play a causal role in development of some diseases, potentially mediated by its role in innate immunity. These results also high-light the potential for automatic confounder selection to improve the robustness of Mendelian randomization analyses. Key MessagesO_LIWe used multivariable Mendelian randomization to estimate the causal effect of CRP levels on various diseases after adjusting for heritable confounders. C_LIO_LIWe proposed a novel computational pipeline for phenome-wide heritable confounder selection using traits from the MRC-IEU OpenGWAS database. C_LIO_LIOur study did not find evidence of a causal effect of CRP on multiple diseases, except rheuma-toid arthritis and schizophrenia. C_LIO_LIOur study highlights the role of CRP as an indicator of inflammation rather than a causal factor in disease risk, suggesting that previous MR analyses may have been biased by heritable confounding. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Shi, R., Morrison, J.. 2025-01-12. Multivariable Mendelian Randomization adjusting for heritable confounding analyzes the causal effects of C-reactive protein on multiple diseases. https://doi.org/10.1101/2025.01.08.631816

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗